Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors

Brain Research

Volumn 785, Issue 1, 1998, Pages 136-142

  Davidson, Elyad M ^b   Carlton, Susan M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Glutamate antagonist; NMDA; Nociception; Spontaneous pain

Indexed keywords

DEXTRORPHAN; FORMALDEHYDE; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; DOSE RESPONSE; MALE; MYELINATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; DEXTRORPHAN; FOOT; FORMALDEHYDE; INJECTIONS, INTRADERMAL; KETAMINE; MALE; MEMANTINE; MOTOR ACTIVITY; PAIN; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR;

EID: 0032559569     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01396-6     Document Type: Article

References (62)

1. L.M. Aanonsen, G.L. Wilcox, Nociceptive action of excitatory amino acids in the mouse: Effects of spinally administered opioids, phencyclidine and sigma agonists, J. Pharmacol. Exp. Ther. 243 (1987) 9-19.
2. F.V. Abbott, K.B.J. Franklin, R.F. Westbrook, The formalin test: Scoring properties of the first and second phases of the pain response in rats, Pain 60 (1995) 91-102.
3. H.L. Allen, L.L. Iversen, Phencyclidine, dizocilpine, and cerebrocortical neurons, Science 247 (1990) 221.
4. L. Ambrozi, W. Danielczyk, Treatment of impaired cerebral function in psychogeriatric patients with memantine - results of a phase-II double-blind study, Pharmacopsychiatry 21 (1988) 144-146.
5. R.N. Auer, K.C. Coulter, The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK801, Acta Neuropathol. 87 (1994) 1-7.
6. M. Backonja, G. Arndt, K.A. Gombar, B. Check, M. Zimmermann, Response of chronic neuropathic pain syndromes to ketamine: A preliminary study, Pain 56 (1994) 51-57.
7. G. Battaglia, A. Rustioni, Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey, J. Comp. Neurol. 277 (1988) 302-312.
8. S. Carlton, K. Gondesen, J. Patterson, H. Rees, M. Tsuruoka, W. Willis, Behavioral and physiological effects of intrathecal memantine in a primate model of painful peripheral neuropathy, Am. Pain Society (1994) A-52.
9. 2A receptors in peripheral sensory axons in rat glabrous skin, Brain Res. 763 (1997) 271-275.
10. S.M. Carlton, G.L. Hargett, Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats, Neurosci. Lett. 198 (1995) 115-118.
11. S.M. Carlton, G.L. Hargett, R.E. Coggeshall, Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin, Neurosci. Lett. 197 (1995) 25-28.
12. S.M. Carlton, H. Rees, K. Gondesen, W.D. Willis, Dextrorphan attenuates responses of spinothalamic tract cells in normal and nerve-injured monkeys, Neurosci. Lett. 229 (1997) 169-172.
13. J. Church, D. Lodge, S.C. Berry, Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids, Eur. J. Pharmacol. 111 (1985) 185-190.
14. T.J. Coderre, R. Melzack, The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury, J. Neurosci. 12 (1992) 3665-3670.
15. R.E. Coggeshall, S.M. Carlton, Ultrastructural analysis of NMDA, AMPA and kainate receptors on unmyelinated and myelinated axons in the periphery, J. Comp. Neurol. 764 (1997) 126-132.
16. R.E. Coggeshall, S. Zhou, S.M. Carlton, Opioid receptors on peripheral sensory axons, Brain Res. (1997) (in press).
17. G.L. Collingridge, R.A.J. Lester, Excitatory amino acid receptors in the vertebrate central nervous system, Pharmacol. Rev. 40 (1989) 143-210.
18. G. Davar, A. Hama, A. Deykin, B. Vos, R. Maciewicz, MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy, Brain Res. 553 (1991) 327-330.
19. E.M. Davidson, R.E. Coggeshall, S.M. Carlton, Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test, NeuroReport 8 (1997) 941-946.
20. A.H. Dickenson, A.F. Sullivan, Evidence for a role of the NMDA receptor in the frequency dependant potentiation of rat dorsal horn nociceptive neurones following C fibre stimulation, Neuropharmacology 26 (1987) 1235-1238.
21. A.H. Dickenson, A.F. Sullivan, Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones, Neurosci. Lett. 83 (1987) 207-211.
22. P.M. Dougherty, W.D. Willis, Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application on N-methyl-D-aspartic acid and substance P, Pain 47 (1991) 85-93.
23. P.M. Dougherty, W.D. Willis, Enhanced responses of spinothalamic tract neurons to excitatory amino acids accompany capsaicin-induced sensitization in the monkey, J. Neurosci. 12 (1992) 883-894.
24. D. Dubuisson, S.G. Dennis, The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats, Pain 4 (1977) 161-174.
25. Z. Durrani, A.P. Winnie, E.K. Zsigmond, M.L. Burnett, Ketamine for intravenous regional anesthesia, Anesth. Analg. 68 (1989) 328-332.
26. P.K. Eide, E. Jorum, A. Stubhaug, J. Bremnes, H. Breivik, Relief of postherpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo, Pain 58 (1994) 347-354.
27. P.K. Eide, A. Stubhaug, I. Oye, H. Breivik, Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia, Pain 61 (1995) 221-228.
28. E. Eisenberg, S. LaCross, A.M. Strassman, The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy, Neurosci. Lett. 187 (1995) 17-20.
29. A.D. Finck, S.H. Ngai, Opiate receptor mediation of ketamine analgesia, Anesthesiology 56 (1982) 291-297.
30. J. Haley, A.F. Sullivan, A.H. Dickenson, Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat, Brain Res. 518 (1990) 218-226.
31. C.G. Heapy, A. Jamieson, N.J.W. Russell, Afferent C-fibre and A δ activity in models of inflammation, Br. J. Pharmacol. 90 (1987) 164P.
32. D.L. Jackson, C.B. Graff, J.D. Richardson, K.M. Hargreaves, Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats, Eur. J. Pharmacol. 284 (1995) 321-325.
33. D.L. Jackson, J.D. Richardson, K.M. Hargreaves, Peripheral administration of excitatory amino acids modulate nociceptive behavior in rats, Soc. Neurosci. 20 (1994) 1390.
34. N.B. Lawand, W.D. Willis, K.N. Westlund, Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats, Eur. J. Pharmacol. 324 (1997) 169-177.
35. J. Mao, D.D. Price, R.L. Hayes, J. Lu, D.J. Mayer, Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy, Brain Res. 598 (1992) 271-278.
36. J. Mao, D.D. Price, R.L. Hayes, J. Lu, D.J. Mayer, H. Frenk, Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy, Brain Res. 605 (1993) 164-168.
37. L.C. Mathisen, P. Skjelbred, L.A. Skoglund, I. Oye, Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain, Pain 61 (1995) 215-220.
38. A. Maurset, L.A. Skoglund, O. Hustveit, I. Oye, Comparison of ketamine and pethidine in experimental and postoperative pain, Pain 36 (1989) 37-41.
39. N. Mjellem-Joly, A. Lund, O.-G. Berge, K. Hole, Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acids, Neurosci. Lett. 133 (1991) 121-124.
40. K.A. Nelson, K.M. Park, E. Robinovitz, M.B. Max, High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia, Neurology (1997) (in press).
41. V. Neugebauer, J. Kornhuber, T. Lucke, H.-G. Schaible, The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones, NeuroReport 4 (1993) 1259-1262.
42. J.W. Olney, J. Labruyere, M.T. Price, Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science 244 (1989) 1360-1362.
43. J.W. Olney, J. Labruyere, G. Wang, D.F. Wozniak, M.T. Price, M.A. Sesma, NMDA antagonist neurotoxicity: Mechanism and prevention, Science 254 (1991) 1515-1518.
44. I. Oye, O. Paulsen, A. Maurset, Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors, J. Pharmacol. Exp. Ther. 260 (1992) 1209-1213.
45. J. Palecek, P.M. Dougherty, S.H. Kim, V. Paleckova, H. Lekan, J.M. Chung, S.M. Carlton, W.D. Willis, Responses of spinothalamic tract neurons to mechanical and thermal stimuli in an experimental model of peripheral neuropathy in primates, J. Neurophysiol. 68 (1992) 1951-1966.
46. G.M. Pekoe, D.J. Smith, The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine, Pain 12 (1982) 57-63.
47. D.D. Price, J. Mao, H. Frenk, D.J. Mayer, The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man, Pain 59 (1994) 165-174.
48. C.E. Prioleau, R.E. Coggeshall, S.M. Carlton, Peripheral NMDA receptors play a role in capsaicin hyperalgesia, Soc. Neurosci. 22 (1996) 1370.
49. S. Puig, L.S. Sorkin, Formalin-evoked activity in identified primary afferent fibers: Systemic lidocaine suppresses phase-2 activity, Pain 64 (1996) 345-355.
50. J. Qian, S. Brown, S.M. Carlton, Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy, Brain Res. 715 (1996) 51-62.
51. J.M. Rabey, P. Nissipeanu, A.D. Korczyn, Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease, J. Neural Trans. 4 (1992) 277-282.
52. Z. Seltzer, S. Cohn, R. Ginzburg, B. Beilin, Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge, Pain 45 (1991) 69-75.
53. M. Shibata, T. Ohkubo, H. Takahashi, R. Inoki, Modified formalin test: Characteristic biphasic pain response, Pain 38 (1989) 347-352.
54. D.A. Simone, T.K. Baumann, J.G. Collins, R.H. LaMotte, Sensitization of cat dorsal horn neurons to innocuous mechanical stimulation after intradermal injection of capsaicin, Brain Res. 486 (1989) 185-189.
55. S.R. Skilling, D.H. Smullin, A.A. Larson, Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation, J. Neurochem. 51 (1988) 127-132.
56. L.S. Sorkin, K.N. Westlund, K.A. Sluka, P.M. Dougherty, W.D. Willis, Neural changes in acute arthritis in monkeys: IV. Time course of amino acid release into the lumbar dorsal horn, Brain Res. Rev. 17 (1992) 39-50.
57. M. Sosnowski, Pain management: Physiopathology, future research and endpoints, Suppl. Care Cancer 1 (1993) 79-88.
58. C.F. Stannard, G.E. Porter, Ketamine hydrochloride in the treatment of phantom limb pain, Pain 54 (1993) 227-230.
59. M. Tal, G.J. Bennett, Neuropathic pain sensations are differentially sensitive to dextrorphan, NeuroReport 5 (1994) 1438-1440.
60. T. Warncke, E. Jorum, A. Stubhaug, Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action, Neurosci. Lett. 227 (1997) 1-4.
61. X.-M. Yu, B.J. Sessle, D.A. Haas, A. Izzo, H. Vernon, J.W. Hu, Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats, Pain 68 (1996) 169-178.
62. S. Zhou, L. Bonasera, S.M. Carlton, Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats, NeuroReport 7 (1996) 895-900.